Strategic Improvement of Oral Antineoplastic Investigational Agents Compliance

Strategic Improvement of Oral Antineoplastic Investigational Agents Compliance

Background: The use of oral antineoplastic agents has increased in cancer medicine. However, the convenience of oral medication carries the risk of nonadherence and dosing errors, which could jeopardize therapeutic benefits and patient safety. This is a quality improvement project to investigate rea...

Full description

Bibliographic Details
Main Authors: Anas Alshawa, Jing Gong, Valerie Marcott, Rabia Khan, Valentine Boving, Lakeshia Brown, Jeff Beno, Ed Kheder, Siqing Fu
Format: Article
Language:English
Published: Innovative Healthcare Institute 2019-02-01
Series:Global Journal on Quality and Safety in Healthcare
Subjects:
clinical trials
compliance
investigational
nonadherence
oral antineoplastic
phase 1
quality improvement
Online Access:https://jqsh.org/doi/pdf/10.4103/JQSH.JQSH_23_18

Internet

https://jqsh.org/doi/pdf/10.4103/JQSH.JQSH_23_18

Similar Items